Finasteride - Global Market Outlook (2020-2028)
According to Stratistics MRC, the Global Finasteride Market is accounted for $112.75 million in 2020 and is expected to reach $160.34 million by 2028 growing at a CAGR of 4.5% during the forecast period. Rising cases of prostate cancer, and growing consumers spending on hair care products, are driving the market growth. However, possible side effects associated with the finasteride tablets hampers the growth of the market.
Finasteride serves as an active ingredient in manufacturing drugs for controlling baldness and prostate cancer in men. The products improve BPH symptoms and decrease the urge for urine and contribute to better urinating flow with less strain. The active ingredient works to decrease natural body hormone (DHT), which serves as the main factor for prostate growth.
Based on the product, the 1 mg tablet segment is going to have lucrative growth during the forecast period as 1mg products are 5-alpha reductase inhibitor which blocks body production of a male hormone that reduces hair loss in the scalp. Finasteride products are very effective and low cost, thereby stimulates finasteride market size. Growing demand for quick remedy pharma drugs for treating baldness and hair loss using 1mg tablet will further propel the finasteride market.
By geography, Europe is going to have high growth during the forecast period as Europe is at the highest risk of suffering from bald-headedness and the figures are expected to ascend rapidly in the forthcoming years. Moreover, the treatment for Alopecia and increased hair loss problems due to ageing is expected to grow significantly over the forecast timeframe which will support the finasteride market in this region.
Some of the key players profiled in the Finasteride Market include Dr. Reddy's Laboratories, Zhejiang CONBA Pharmaceutical Co., Ltd., Teva Pharmaceuticals , Novartis, Accord Healthcare, Actavis, Cipla, Relonchem Limited, Merck and Henan Topfond Pharmaceutical Co., Ltd.
Applications Covered:
All the customers of this report will be entitled to receive one of the following free customization options:
Finasteride serves as an active ingredient in manufacturing drugs for controlling baldness and prostate cancer in men. The products improve BPH symptoms and decrease the urge for urine and contribute to better urinating flow with less strain. The active ingredient works to decrease natural body hormone (DHT), which serves as the main factor for prostate growth.
Based on the product, the 1 mg tablet segment is going to have lucrative growth during the forecast period as 1mg products are 5-alpha reductase inhibitor which blocks body production of a male hormone that reduces hair loss in the scalp. Finasteride products are very effective and low cost, thereby stimulates finasteride market size. Growing demand for quick remedy pharma drugs for treating baldness and hair loss using 1mg tablet will further propel the finasteride market.
By geography, Europe is going to have high growth during the forecast period as Europe is at the highest risk of suffering from bald-headedness and the figures are expected to ascend rapidly in the forthcoming years. Moreover, the treatment for Alopecia and increased hair loss problems due to ageing is expected to grow significantly over the forecast timeframe which will support the finasteride market in this region.
Some of the key players profiled in the Finasteride Market include Dr. Reddy's Laboratories, Zhejiang CONBA Pharmaceutical Co., Ltd., Teva Pharmaceuticals , Novartis, Accord Healthcare, Actavis, Cipla, Relonchem Limited, Merck and Henan Topfond Pharmaceutical Co., Ltd.
Applications Covered:
- Prostate Treatment
- Hair Treatment
- Medical Uses
- Benign Prostatic Hyperplasia
- Male Pattern Baldness
- 1 mg Tablet
- 5 mg Tablet
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Product Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL FINASTERIDE MARKET, BY APPLICATION
5.1 Introduction
5.2 Prostate Treatment
5.2.1 Prostate Enlargement
5.2.2 Prostate Cancer
5.2.3 Hormone Therapy (Transgender Women)
5.3 Hair Treatment
5.3.1 Scalp Hair Loss
5.3.2 Excessive Hair Growth
5.4 Medical Uses
5.5 Benign Prostatic Hyperplasia
5.6 Male Pattern Baldness
6 GLOBAL FINASTERIDE MARKET, BY PRODUCT
6.1 Introduction
6.2 1 mg Tablet
6.3 5 mg Tablet
7 GLOBAL FINASTERIDE MARKET, BY GEOGRAPHY
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 KEY DEVELOPMENTS
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 COMPANY PROFILING
9.1 Dr. Reddy's Laboratories
9.2 Zhejiang CONBA Pharmaceutical Co., Ltd.
9.3 Teva Pharmaceuticals
9.4 Novartis
9.5 Accord Healthcare
9.6 Actavis
9.7 Cipla
9.8 Relonchem Limited
9.9 Merck
9.10 Henan Topfond Pharmaceutical Co., Ltd.
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Product Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL FINASTERIDE MARKET, BY APPLICATION
5.1 Introduction
5.2 Prostate Treatment
5.2.1 Prostate Enlargement
5.2.2 Prostate Cancer
5.2.3 Hormone Therapy (Transgender Women)
5.3 Hair Treatment
5.3.1 Scalp Hair Loss
5.3.2 Excessive Hair Growth
5.4 Medical Uses
5.5 Benign Prostatic Hyperplasia
5.6 Male Pattern Baldness
6 GLOBAL FINASTERIDE MARKET, BY PRODUCT
6.1 Introduction
6.2 1 mg Tablet
6.3 5 mg Tablet
7 GLOBAL FINASTERIDE MARKET, BY GEOGRAPHY
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 KEY DEVELOPMENTS
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 COMPANY PROFILING
9.1 Dr. Reddy's Laboratories
9.2 Zhejiang CONBA Pharmaceutical Co., Ltd.
9.3 Teva Pharmaceuticals
9.4 Novartis
9.5 Accord Healthcare
9.6 Actavis
9.7 Cipla
9.8 Relonchem Limited
9.9 Merck
9.10 Henan Topfond Pharmaceutical Co., Ltd.
LIST OF TABLES
Table 1 Global Finasteride Market Outlook, By Region (2019-2028) (US $MN)
Table 2 Global Finasteride Market Outlook, By Application (2019-2028) (US $MN)
Table 3 Global Finasteride Market Outlook, By Prostate Treatment (2019-2028) (US $MN)
Table 4 Global Finasteride Market Outlook, By Prostate Enlargement (2019-2028) (US $MN)
Table 5 Global Finasteride Market Outlook, By Prostate Cancer (2019-2028) (US $MN)
Table 6 Global Finasteride Market Outlook, By Hormone Therapy (Transgender Women) (2019-2028) (US $MN)
Table 7 Global Finasteride Market Outlook, By Hair Treatment (2019-2028) (US $MN)
Table 8 Global Finasteride Market Outlook, By Scalp Hair Loss (2019-2028) (US $MN)
Table 9 Global Finasteride Market Outlook, By Excessive Hair Growth (2019-2028) (US $MN)
Table 10 Global Finasteride Market Outlook, By Medical Uses (2019-2028) (US $MN)
Table 11 Global Finasteride Market Outlook, By Benign Prostatic Hyperplasia (2019-2028) (US $MN)
Table 12 Global Finasteride Market Outlook, By Male Pattern Baldness (2019-2028) (US $MN)
Table13 Global Finasteride Market Outlook, By Product (2019-2028) (US $MN)
Table 14 Global Finasteride Market Outlook, By 1 mg Tablet (2019-2028) (US $MN)
Table 15 Global Finasteride Market Outlook, By 5 mg Tablet (2019-2028) (US $MN)
Table 16 North America Finasteride Market Outlook, By Country (2019-2028) (US $MN)
Table 17 North America Finasteride Market Outlook, By Application (2019-2028) (US $MN)
Table 18 North America Finasteride Market Outlook, By Prostate Treatment (2019-2028) (US $MN)
Table 19 North America Finasteride Market Outlook, By Prostate Enlargement (2019-2028) (US $MN)
Table 20 North America Finasteride Market Outlook, By Prostate Cancer (2019-2028) (US $MN)
Table 21 North America Finasteride Market Outlook, By Hormone Therapy (Transgender Women) (2019-2028) (US $MN)
Table 22 North America Finasteride Market Outlook, By Hair Treatment (2019-2028) (US $MN)
Table 23 North America Finasteride Market Outlook, By Scalp Hair Loss (2019-2028) (US $MN)
Table 24 North America Finasteride Market Outlook, By Excessive Hair Growth (2019-2028) (US $MN)
Table 25 North America Finasteride Market Outlook, By Medical Uses (2019-2028) (US $MN)
Table 26 North America Finasteride Market Outlook, By Benign Prostatic Hyperplasia (2019-2028) (US $MN)
Table 27 North America Finasteride Market Outlook, By Male Pattern Baldness (2019-2028) (US $MN)
Table 28 North America Finasteride Market Outlook, By Product (2019-2028) (US $MN)
Table 29 North America Finasteride Market Outlook, By 1 mg Tablet (2019-2028) (US $MN)
Table 30 North America Finasteride Market Outlook, By 5 mg Tablet (2019-2028) (US $MN)
Table 31 Europe Finasteride Market Outlook, By Country (2019-2028) (US $MN)
Table 32 Europe Finasteride Market Outlook, By Application (2019-2028) (US $MN)
Table 33 Europe Finasteride Market Outlook, By Prostate Treatment (2019-2028) (US $MN)
Table 34 Europe Finasteride Market Outlook, By Prostate Enlargement (2019-2028) (US $MN)
Table 35 Europe Finasteride Market Outlook, By Prostate Cancer (2019-2028) (US $MN)
Table 36 Europe Finasteride Market Outlook, By Hormone Therapy (Transgender Women) (2019-2028) (US $MN)
Table 37 Europe Finasteride Market Outlook, By Hair Treatment (2019-2028) (US $MN)
Table 38 Europe Finasteride Market Outlook, By Scalp Hair Loss (2019-2028) (US $MN)
Table 39 Europe Finasteride Market Outlook, By Excessive Hair Growth (2019-2028) (US $MN)
Table 40 Europe Finasteride Market Outlook, By Medical Uses (2019-2028) (US $MN)
Table 41 Europe Finasteride Market Outlook, By Benign Prostatic Hyperplasia (2019-2028) (US $MN)
Table 42 Europe Finasteride Market Outlook, By Male Pattern Baldness (2019-2028) (US $MN)
Table 43 Europe Finasteride Market Outlook, By Product (2019-2028) (US $MN)
Table 44 Europe Finasteride Market Outlook, By 1 mg Tablet (2019-2028) (US $MN)
Table 45 Europe Finasteride Market Outlook, By 5 mg Tablet (2019-2028) (US $MN)
Table 46 Asia Pacific Finasteride Market Outlook, By Country (2019-2028) (US $MN)
Table 47 Asia Pacific Finasteride Market Outlook, By Application (2019-2028) (US $MN)
Table 48 Asia Pacific Finasteride Market Outlook, By Prostate Treatment (2019-2028) (US $MN)
Table 49 Asia Pacific Finasteride Market Outlook, By Prostate Enlargement (2019-2028) (US $MN)
Table 50 Asia Pacific Finasteride Market Outlook, By Prostate Cancer (2019-2028) (US $MN)
Table 51 Asia Pacific Finasteride Market Outlook, By Hormone Therapy (Transgender Women) (2019-2028) (US $MN)
Table 52 Asia Pacific Finasteride Market Outlook, By Hair Treatment (2019-2028) (US $MN)
Table 53 Asia Pacific Finasteride Market Outlook, By Scalp Hair Loss (2019-2028) (US $MN)
Table 54 Asia Pacific Finasteride Market Outlook, By Excessive Hair Growth (2019-2028) (US $MN)
Table 55 Asia Pacific Finasteride Market Outlook, By Medical Uses (2019-2028) (US $MN)
Table 56 Asia Pacific Finasteride Market Outlook, By Benign Prostatic Hyperplasia (2019-2028) (US $MN)
Table 57 Asia Pacific Finasteride Market Outlook, By Male Pattern Baldness (2019-2028) (US $MN)
Table 58 Asia Pacific Finasteride Market Outlook, By Product (2019-2028) (US $MN)
Table 59 Asia Pacific Finasteride Market Outlook, By 1 mg Tablet (2019-2028) (US $MN)
Table 60 Asia Pacific Finasteride Market Outlook, By 5 mg Tablet (2019-2028) (US $MN)
Table 61 South America Finasteride Market Outlook, By Country (2019-2028) (US $MN)
Table 62 South America Finasteride Market Outlook, By Application (2019-2028) (US $MN)
Table 63 South America Finasteride Market Outlook, By Prostate Treatment (2019-2028) (US $MN)
Table 64 South America Finasteride Market Outlook, By Prostate Enlargement (2019-2028) (US $MN)
Table 65 South America Finasteride Market Outlook, By Prostate Cancer (2019-2028) (US $MN)
Table 66 South America Finasteride Market Outlook, By Hormone Therapy (Transgender Women) (2019-2028) (US $MN)
Table 67 South America Finasteride Market Outlook, By Hair Treatment (2019-2028) (US $MN)
Table 68 South America Finasteride Market Outlook, By Scalp Hair Loss (2019-2028) (US $MN)
Table 69 South America Finasteride Market Outlook, By Excessive Hair Growth (2019-2028) (US $MN)
Table 70 South America Finasteride Market Outlook, By Medical Uses (2019-2028) (US $MN)
Table 71 South America Finasteride Market Outlook, By Benign Prostatic Hyperplasia (2019-2028) (US $MN)
Table 72 South America Finasteride Market Outlook, By Male Pattern Baldness (2019-2028) (US $MN)
Table 73 South America Finasteride Market Outlook, By Product (2019-2028) (US $MN)
Table 74 South America Finasteride Market Outlook, By 1 mg Tablet (2019-2028) (US $MN)
Table 75 South America Finasteride Market Outlook, By 5 mg Tablet (2019-2028) (US $MN)
Table 76 Middle East & Africa Finasteride Market Outlook, By Country (2019-2028) (US $MN)
Table 77 Middle East & Africa Finasteride Market Outlook, By Application (2019-2028) (US $MN)
Table 78 Middle East & Africa Finasteride Market Outlook, By Prostate Treatment (2019-2028) (US $MN)
Table 79 Middle East & Africa Finasteride Market Outlook, By Prostate Enlargement (2019-2028) (US $MN)
Table 80 Middle East & Africa Finasteride Market Outlook, By Prostate Cancer (2019-2028) (US $MN)
Table 81 Middle East & Africa Finasteride Market Outlook, By Hormone Therapy (Transgender Women) (2019-2028) (US $MN)
Table 82 Middle East & Africa Finasteride Market Outlook, By Hair Treatment (2019-2028) (US $MN)
Table 83 Middle East & Africa Finasteride Market Outlook, By Scalp Hair Loss (2019-2028) (US $MN)
Table 84 Middle East & Africa Finasteride Market Outlook, By Excessive Hair Growth (2019-2028) (US $MN)
Table 85 Middle East & Africa Finasteride Market Outlook, By Medical Uses (2019-2028) (US $MN)
Table 86 Middle East & Africa Finasteride Market Outlook, By Benign Prostatic Hyperplasia (2019-2028) (US $MN)
Table 87 Middle East & Africa Finasteride Market Outlook, By Male Pattern Baldness (2019-2028) (US $MN)
Table 88 Middle East & Africa Finasteride Market Outlook, By Product (2019-2028) (US $MN)
Table 89 Middle East & Africa Finasteride Market Outlook, By 1 mg Tablet (2019-2028) (US $MN)
Table 90 Middle East & Africa Finasteride Market Outlook, By 5 mg Tablet (2019-2028) (US $MN)
Table 1 Global Finasteride Market Outlook, By Region (2019-2028) (US $MN)
Table 2 Global Finasteride Market Outlook, By Application (2019-2028) (US $MN)
Table 3 Global Finasteride Market Outlook, By Prostate Treatment (2019-2028) (US $MN)
Table 4 Global Finasteride Market Outlook, By Prostate Enlargement (2019-2028) (US $MN)
Table 5 Global Finasteride Market Outlook, By Prostate Cancer (2019-2028) (US $MN)
Table 6 Global Finasteride Market Outlook, By Hormone Therapy (Transgender Women) (2019-2028) (US $MN)
Table 7 Global Finasteride Market Outlook, By Hair Treatment (2019-2028) (US $MN)
Table 8 Global Finasteride Market Outlook, By Scalp Hair Loss (2019-2028) (US $MN)
Table 9 Global Finasteride Market Outlook, By Excessive Hair Growth (2019-2028) (US $MN)
Table 10 Global Finasteride Market Outlook, By Medical Uses (2019-2028) (US $MN)
Table 11 Global Finasteride Market Outlook, By Benign Prostatic Hyperplasia (2019-2028) (US $MN)
Table 12 Global Finasteride Market Outlook, By Male Pattern Baldness (2019-2028) (US $MN)
Table13 Global Finasteride Market Outlook, By Product (2019-2028) (US $MN)
Table 14 Global Finasteride Market Outlook, By 1 mg Tablet (2019-2028) (US $MN)
Table 15 Global Finasteride Market Outlook, By 5 mg Tablet (2019-2028) (US $MN)
Table 16 North America Finasteride Market Outlook, By Country (2019-2028) (US $MN)
Table 17 North America Finasteride Market Outlook, By Application (2019-2028) (US $MN)
Table 18 North America Finasteride Market Outlook, By Prostate Treatment (2019-2028) (US $MN)
Table 19 North America Finasteride Market Outlook, By Prostate Enlargement (2019-2028) (US $MN)
Table 20 North America Finasteride Market Outlook, By Prostate Cancer (2019-2028) (US $MN)
Table 21 North America Finasteride Market Outlook, By Hormone Therapy (Transgender Women) (2019-2028) (US $MN)
Table 22 North America Finasteride Market Outlook, By Hair Treatment (2019-2028) (US $MN)
Table 23 North America Finasteride Market Outlook, By Scalp Hair Loss (2019-2028) (US $MN)
Table 24 North America Finasteride Market Outlook, By Excessive Hair Growth (2019-2028) (US $MN)
Table 25 North America Finasteride Market Outlook, By Medical Uses (2019-2028) (US $MN)
Table 26 North America Finasteride Market Outlook, By Benign Prostatic Hyperplasia (2019-2028) (US $MN)
Table 27 North America Finasteride Market Outlook, By Male Pattern Baldness (2019-2028) (US $MN)
Table 28 North America Finasteride Market Outlook, By Product (2019-2028) (US $MN)
Table 29 North America Finasteride Market Outlook, By 1 mg Tablet (2019-2028) (US $MN)
Table 30 North America Finasteride Market Outlook, By 5 mg Tablet (2019-2028) (US $MN)
Table 31 Europe Finasteride Market Outlook, By Country (2019-2028) (US $MN)
Table 32 Europe Finasteride Market Outlook, By Application (2019-2028) (US $MN)
Table 33 Europe Finasteride Market Outlook, By Prostate Treatment (2019-2028) (US $MN)
Table 34 Europe Finasteride Market Outlook, By Prostate Enlargement (2019-2028) (US $MN)
Table 35 Europe Finasteride Market Outlook, By Prostate Cancer (2019-2028) (US $MN)
Table 36 Europe Finasteride Market Outlook, By Hormone Therapy (Transgender Women) (2019-2028) (US $MN)
Table 37 Europe Finasteride Market Outlook, By Hair Treatment (2019-2028) (US $MN)
Table 38 Europe Finasteride Market Outlook, By Scalp Hair Loss (2019-2028) (US $MN)
Table 39 Europe Finasteride Market Outlook, By Excessive Hair Growth (2019-2028) (US $MN)
Table 40 Europe Finasteride Market Outlook, By Medical Uses (2019-2028) (US $MN)
Table 41 Europe Finasteride Market Outlook, By Benign Prostatic Hyperplasia (2019-2028) (US $MN)
Table 42 Europe Finasteride Market Outlook, By Male Pattern Baldness (2019-2028) (US $MN)
Table 43 Europe Finasteride Market Outlook, By Product (2019-2028) (US $MN)
Table 44 Europe Finasteride Market Outlook, By 1 mg Tablet (2019-2028) (US $MN)
Table 45 Europe Finasteride Market Outlook, By 5 mg Tablet (2019-2028) (US $MN)
Table 46 Asia Pacific Finasteride Market Outlook, By Country (2019-2028) (US $MN)
Table 47 Asia Pacific Finasteride Market Outlook, By Application (2019-2028) (US $MN)
Table 48 Asia Pacific Finasteride Market Outlook, By Prostate Treatment (2019-2028) (US $MN)
Table 49 Asia Pacific Finasteride Market Outlook, By Prostate Enlargement (2019-2028) (US $MN)
Table 50 Asia Pacific Finasteride Market Outlook, By Prostate Cancer (2019-2028) (US $MN)
Table 51 Asia Pacific Finasteride Market Outlook, By Hormone Therapy (Transgender Women) (2019-2028) (US $MN)
Table 52 Asia Pacific Finasteride Market Outlook, By Hair Treatment (2019-2028) (US $MN)
Table 53 Asia Pacific Finasteride Market Outlook, By Scalp Hair Loss (2019-2028) (US $MN)
Table 54 Asia Pacific Finasteride Market Outlook, By Excessive Hair Growth (2019-2028) (US $MN)
Table 55 Asia Pacific Finasteride Market Outlook, By Medical Uses (2019-2028) (US $MN)
Table 56 Asia Pacific Finasteride Market Outlook, By Benign Prostatic Hyperplasia (2019-2028) (US $MN)
Table 57 Asia Pacific Finasteride Market Outlook, By Male Pattern Baldness (2019-2028) (US $MN)
Table 58 Asia Pacific Finasteride Market Outlook, By Product (2019-2028) (US $MN)
Table 59 Asia Pacific Finasteride Market Outlook, By 1 mg Tablet (2019-2028) (US $MN)
Table 60 Asia Pacific Finasteride Market Outlook, By 5 mg Tablet (2019-2028) (US $MN)
Table 61 South America Finasteride Market Outlook, By Country (2019-2028) (US $MN)
Table 62 South America Finasteride Market Outlook, By Application (2019-2028) (US $MN)
Table 63 South America Finasteride Market Outlook, By Prostate Treatment (2019-2028) (US $MN)
Table 64 South America Finasteride Market Outlook, By Prostate Enlargement (2019-2028) (US $MN)
Table 65 South America Finasteride Market Outlook, By Prostate Cancer (2019-2028) (US $MN)
Table 66 South America Finasteride Market Outlook, By Hormone Therapy (Transgender Women) (2019-2028) (US $MN)
Table 67 South America Finasteride Market Outlook, By Hair Treatment (2019-2028) (US $MN)
Table 68 South America Finasteride Market Outlook, By Scalp Hair Loss (2019-2028) (US $MN)
Table 69 South America Finasteride Market Outlook, By Excessive Hair Growth (2019-2028) (US $MN)
Table 70 South America Finasteride Market Outlook, By Medical Uses (2019-2028) (US $MN)
Table 71 South America Finasteride Market Outlook, By Benign Prostatic Hyperplasia (2019-2028) (US $MN)
Table 72 South America Finasteride Market Outlook, By Male Pattern Baldness (2019-2028) (US $MN)
Table 73 South America Finasteride Market Outlook, By Product (2019-2028) (US $MN)
Table 74 South America Finasteride Market Outlook, By 1 mg Tablet (2019-2028) (US $MN)
Table 75 South America Finasteride Market Outlook, By 5 mg Tablet (2019-2028) (US $MN)
Table 76 Middle East & Africa Finasteride Market Outlook, By Country (2019-2028) (US $MN)
Table 77 Middle East & Africa Finasteride Market Outlook, By Application (2019-2028) (US $MN)
Table 78 Middle East & Africa Finasteride Market Outlook, By Prostate Treatment (2019-2028) (US $MN)
Table 79 Middle East & Africa Finasteride Market Outlook, By Prostate Enlargement (2019-2028) (US $MN)
Table 80 Middle East & Africa Finasteride Market Outlook, By Prostate Cancer (2019-2028) (US $MN)
Table 81 Middle East & Africa Finasteride Market Outlook, By Hormone Therapy (Transgender Women) (2019-2028) (US $MN)
Table 82 Middle East & Africa Finasteride Market Outlook, By Hair Treatment (2019-2028) (US $MN)
Table 83 Middle East & Africa Finasteride Market Outlook, By Scalp Hair Loss (2019-2028) (US $MN)
Table 84 Middle East & Africa Finasteride Market Outlook, By Excessive Hair Growth (2019-2028) (US $MN)
Table 85 Middle East & Africa Finasteride Market Outlook, By Medical Uses (2019-2028) (US $MN)
Table 86 Middle East & Africa Finasteride Market Outlook, By Benign Prostatic Hyperplasia (2019-2028) (US $MN)
Table 87 Middle East & Africa Finasteride Market Outlook, By Male Pattern Baldness (2019-2028) (US $MN)
Table 88 Middle East & Africa Finasteride Market Outlook, By Product (2019-2028) (US $MN)
Table 89 Middle East & Africa Finasteride Market Outlook, By 1 mg Tablet (2019-2028) (US $MN)
Table 90 Middle East & Africa Finasteride Market Outlook, By 5 mg Tablet (2019-2028) (US $MN)
